SCHEMBL7058843

SCHEMBL7058843

CC(C)CCC[N]CC(C)C

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL277920 0.85 LMNA (0.45) LMNA
SCHEMBL7054428 0.82 TRPA1 (0.33) LMNATRPA1
SCHEMBL271457 0.78
SCHEMBL9469496 0.77 LMNA (0.50) LMNATRPA1
SCHEMBL9468910 0.77 LMNA (0.50) LMNATRPA1
SCHEMBL3296182 0.77 LMNA (0.50) LMNATRPA1
SCHEMBL9469100 0.77 LMNA (0.50) LMNATRPA1
SCHEMBL5932824 0.77 LMNA (0.50) LMNATRPA1
SCHEMBL7058524 0.76 LMNA (0.38) LMNA
SCHEMBL6176538 0.76 NAAA (0.36) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994108-B1 PROCESS FOR PRODUCING 2-HYDROXYBENZAMIDE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-05-14 EP disclosed
US-6197970-B1 REACTING WITH SECONDARY OR TERTIARY AMINE; DEBLOCKING, DEPROTECTING ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0994108-A1 PROCESS FOR PRODUCING 2-HYDROXYBENZAMIDE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed